High warfarin sensitivity in carriers of CYP2C9*35 is determined by the impaired interaction with P450 oxidoreductase.

Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the updraftplus domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /home/francyq/www/wp-includes/functions.php on line 6114
High warfarin sensitivity in carriers of CYP2C9*35 is determined by the impaired interaction with P450 oxidoreductase. - Francesco Oteri

High warfarin sensitivity in carriers of CYP2C9*35 is determined by the impaired interaction with P450 oxidoreductase.

Lee, M.-Y., Borgiani, P., Johansson, I., Oteri, F., Mkrtchian, S., Falconi, M., & Ingelman-Sundberg, M. (2013).
The Pharmacogenomics Journal, 14(4), 343–349.
Read the paper